Top Markets
#1 Islamic Coin Islamic Coin +155.95%
#2 Siren Siren +37.05%
#3 Cysic Cysic +20.57%
#4 Venom Venom +20.55%
#5 Arowana Arowana +18.48%
#6 Verus Coin Verus Coin +15.50%
#7 Perle Perle +14.26%
#8 KUB Coin KUB Coin +12.84%
#9 RedStone RedStone +12.47%
#10 OpenEden OpenEden +12.20%
Coin of the day
Islamic Coin Islamic Coin
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
PCL, Inc. PCL, Inc.

PCL, Inc.

241820
शेयरों में रैंक #31786
PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic... PCL, Inc. specializes in providing sophisticated multiplex in vitro diagnostic (IVD) solutions, encompassing both diagnostic products and specialized platform services. The company's primary offerings include comprehensive multiplex kits designed to detect antibodies to Human Immunodeficiency Virus (HIV) types 1 and 2, Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human T-lymphotropic Virus (HTLV) types 1 and 2. These kits also identify specific antigens such as HIV p24, HCV core, and HBV surface markers in human serum or plasma samples. In addition to these, PCL markets Ai, a rapid diagnostic test kit capable of typing influenza A and B strains; Cancer6, a screening kit for multiple tumor biomarkers; and the sciLINER LATERAL FLOW DISPENSER, an advanced dispensing device for membrane materials featuring active visual drop volume control. Beyond its product portfolio, PCL offers valuable platform services. These include a sol-gel spotting service, which immobilizes client-specified materials using the proprietary SolB reagent, and an SG ID service, providing customers with identified molecules of interest securely immobilized within the SolB reagent. PCL, Inc. is headquartered in Seoul, South Korea.
शेयर मूल्य
$0.21291741
अंतिम समन्वयन: 2025-04-18
मार्केट कैप
$12.07M
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
0.00%
देश
KR
व्यापार PCL, Inc. (241820)

श्रेणी

Healthcare
PCL, Inc. (241820) के लिए P/B अनुपात
August 2026 को P/B अनुपात TTM: 0.31
PCL, Inc. की नवीनतम वित्तीय रिपोर्ट और शेयर मूल्य के अनुसार, कंपनी का वर्तमान P/B अनुपात (TTM) 0.31 है। 2023 के अंत में, कंपनी का P/B अनुपात 4.33 था।
PCL, Inc. के लिए 2015 से 2026 तक P/B अनुपात का इतिहास
हर वर्ष के अंत में P/B अनुपात
वर्ष P/B अनुपात परिवर्तन
2026 (TTM) 0.31 -92.92%
2024 4.37 0.92%
2023 4.33 -22.84%
2022 5.61 -79.76%
2021 27.74 158.91%
2020 10.71 -23.63%
2019 14.03 43.20%
2018 9.80 -11.87%
2017 11.12 -9.46%
2016 12.28 -33.14%
2015 18.36 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए P/B अनुपात
कंपनी P/B अनुपात P/B अनुपात में अंतर देश
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 3.7944 1,126.37%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 5.423 1,652.75%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 2.0146 551.13%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 3.072 892.89%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 4.9725 1,507.14%
US